Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols

The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review

(2020) Ruben Van Paemel et al.   EUROPEAN JOURNAL OF PEDIATRICS

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation

(2019) F. Spreafico et al.   BONE MARROW TRANSPLANTATION

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group–International Society of Paediatric Oncology Wilms' tumour protocol database

(2018) Jesper Brok et al.   LANCET ONCOLOGY

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group

(2018) Elizabeth A. Mullen et al.   JOURNAL OF CLINICAL ONCOLOGY

The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol

(2018) Gordan M. Vujanić et al.   Nature Reviews Urology

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol

(2017) Marry M. van den Heuvel-Eibrink et al.   Nature Reviews Urology

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study

(2016) Tasnim Chagtai et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group

(2016) Eric J. Gratias et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)

(2015) M.M. van den Heuvel-Eibrink et al.   EUROPEAN JOURNAL OF CANCER

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

(2015) Jeffrey S. Dome et al.   JOURNAL OF CLINICAL ONCOLOGY

Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

(2015) Kathy Pritchard-Jones et al.   LANCET

Gain of 1q is a marker of poor prognosis in Wilms' tumors

(2013) H. Segers et al.   GENES CHROMOSOMES & CANCER

An international strategy to determine the role of high dose therapy in recurrent Wilms’ tumour

(2012) Tam C. Ha et al.   EUROPEAN JOURNAL OF CANCER

Update on Relapses in Unilateral Nephroblastoma Registered in 3 Consecutive SIOP/GPOH Studies - A Report from the GPOH-Nephroblastoma Study Group

(2011) R. Furtwängler et al.   KLINISCHE PADIATRIE

Treatment of relapsed Wilms tumors: lessons learned

(2009) Filippo Spreafico et al.   Expert Review of Anticancer Therapy

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

(2007) Marcio Malogolowkin et al.   PEDIATRIC BLOOD & CANCER